Niva Bupa Health Insurance reported a strong financial performance for FY2026, with Profit After Tax (IFRS) soaring 80.4% to ₹366.1 crore. This growth was driven by a 27.4% rise in Gross Written Premium to ₹9,432.9 crore.
Niva Bupa Health Insurance Reports Robust FY2026 Financials
Niva Bupa Health Insurance Company Ltd. announced strong financial results for the fiscal year 2026. Profit After Tax (IFRS) surged by 80.4% to ₹366.1 crore, up from ₹202.9 crore in FY2025. Gross Written Premium (GWP) also saw significant growth, increasing by 27.4% to ₹9,432.9 crore from ₹7,406.7 crore in the previous year.
Reader Takeaway: Strong profit and premium growth driven by retail segment expansion, while managing claims inflation and accounting changes is key.
What just happened
Niva Bupa Health Insurance has reported its financial results for FY2026, showcasing substantial growth in both profitability and premium collection. The company's Profit After Tax (IFRS) increased to ₹366.1 crore, an 80.4% rise year-on-year. Gross Written Premium (GWP) grew by 27.4% to ₹9,432.9 crore.
Why this matters
The robust financial performance indicates healthy business expansion and improved operational efficiency. The significant jump in PAT and GWP suggests strong market acceptance and effective business strategies, which are positive indicators for shareholders.
The backstory
In FY2025, Niva Bupa had reported a GWP of ₹7,406.7 crore and PAT (IFRS) of ₹202.9 crore. The company has been focusing on expanding its retail health segment and its distribution network.
What changes now
The company has appointed Mr. Ashwani Bhatia as an Independent Director and Chairperson, along with Mr. Christopher Patrick Carroll and Ms. Siobhan Djihan Moynihan as Non-Executive Directors. The Annual General Meeting is scheduled for August 12, 2026.
Risks to watch
Investors should monitor the impact of claims cost inflation, with the Retail Health Claims Cost Index at 162. Additionally, the transition to Ind AS reporting from FY2027 could affect financial comparability.
Peer comparison
Niva Bupa's Retail Health market share expanded to 10.1% in FY2026, up from 9.4% in FY2025, indicating a strengthening competitive position.
Context metrics (time-bound)
- Gross Written Premium (FY2026): ₹9,432.9 crore (up 27.4% from FY2025)
- Profit After Tax (IFRS) (FY2026): ₹366.1 crore (up 80.4% from FY2025)
- Retail Health GWP (FY2026): ₹6,581.5 crore (up from ₹4,873.4 crore in FY2025)
- Claims Settlement Ratio (FY2026): 94.4% (up from 92.4% in FY2025)
- Assets Under Management (FY2026): ₹9,669.7 crore (up from ₹8,175.1 crore in FY2025)
What to track next
Focus on the company's strategy to manage rising healthcare costs and the successful transition to Ind AS reporting. Expansion into the mass-affluent segment and digital automation efforts will be crucial for future growth.